Less Ads, More Data, More Tools Register for FREE

Pin to quick picksISG.L Regulatory News (ISG)

  • There is currently no data for ISG

Response to Cathexis

19 Jan 2016 17:49

RNS Number : 3705M
ISG PLC
19 January 2016
 



19 January 2016

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

ISG plc ("ISG" or the "Company")

 

ISG reconfirms its rejection of the offer from Cathexis UK Holdings Limited ("Cathexis") of 143p per share (the "Offer")

 

The Board of ISG notes the announcement by Cathexis that it has today posted to shareholders a further document (the "Response Document") in connection with its unsolicited Offer of 143p per share. The Board has reviewed the Response Document in detail, following which it reconfirms its rejection of the Offer.

 

The Board reminds shareholders that the level of acceptances to the Offer as at the first closing date on 11 January 2016 was only 1.58% of the Company's current issued share capital and that since that date the ISG share price has consistently traded above the Offer price of 143p1.

 

As previously communicated in the document posted to shareholders on 30 December 2015, the Board of ISG, together with its advisers, has carefully considered the merits of the Offer and has unanimously rejected it as significantly undervaluing the Company:

 

· Cathexis' inadequate Offer fails to reflect the recent growth and future potential of ISG's core fit out businesses.

 

· Cathexis is an astute investor which has bought its ISG shares at times when the share price has been low and now sees further value in your ISG shares at your expense.

 

· Cathexis is not paying an adequate premium for control of your Company and your dividend is at risk if it seizes control of your Company.

 

 

ALL ISG SHAREHOLDERS ARE ADVISED TO CONTINUE TO TAKE NO ACTION WHATSOEVER AND TO IGNORE THE OFFER.

 

1. The Daily Official List closing prices of ISG plc shares were 147.0p on 11 January 2016, 148.0p on 12 January 2016, 150.0p on 13 January 2016, 151.5p on 14 January 2016, 150.0p on 15 January 2016 and 150.0p on 18 January 2016.

 

 

Enquiries:

 

ISG plc

David Lawther, Chief Executive Officer

020 7392 5250

Jonathan Houlton, Group Finance Director

 

Numis

Michael Meade

020 7260 1000

Stuart Ord

Ben Stoop

 

Instinctif

Matthew Smallwood, Helen Tarbet

020 7457 2020

 

 

Disclaimer

Numis Securities Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively for ISG and no one else in connection with the Offer and the contents of this announcement and will not be responsible to anyone other than ISG for providing the protections afforded to its clients nor for providing advice in connection with the Offer or any matter referred to herein.

 

Publication on Website

A copy of this announcement will be available on the Company's website (www.isgplc.com) by no later than 12 noon (London time) on 20 January 2016. The content of the website referred to in this announcement is not incorporated into and does not form part of this announcement.

 

Responsibility statement

The Directors of ISG accept responsibility for the information contained in this announcement. To the best of the knowledge and belief of the Directors, who have taken all reasonable care to ensure such is the case, the information contained in this announcement is in accordance with the facts and does not omit anything likely to affect the import of such information.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RSPDMGMMNLGGVZM
Date   Source Headline
20th Mar 201312:02 pmRNSScrip Dividend Scheme
5th Mar 20137:00 amRNSHalf Yearly Report
18th Feb 20139:00 amRNSRe. Interim Results Analyst Presentation
14th Feb 20132:09 pmRNSNotice of Results
31st Dec 20127:00 amRNSTotal Voting Rights
11th Dec 20128:42 amRNSDirector/PDMR Shareholding
7th Dec 20121:58 pmRNSAdditional Listing
7th Dec 20121:43 pmRNSResult of AGM
7th Dec 201212:28 pmRNSReplacement: AGM Statement
7th Dec 20127:00 amRNSAGM Statement
5th Dec 20127:00 amRNSRe Contract
7th Nov 20123:54 pmRNSDirector/PDMR Shareholding
6th Nov 20122:35 pmRNSDirector/PDMR Shareholding
26th Oct 20122:03 pmRNSHolding(s) in Company
26th Oct 20128:00 amRNSAnnual Financial Report
22nd Oct 20127:00 amRNSRe Contract
19th Oct 201210:53 amRNSBlocklisting Interim Review
10th Oct 201210:02 amRNSDirector/PDMR Shareholding
12th Sep 20123:22 pmRNSHolding(s) in Company
11th Sep 20127:00 amRNSFinal Results
15th Aug 201210:45 amRNSHolding(s) in Company
14th Aug 20127:00 amRNSRe Contract
8th Aug 20127:00 amRNSRe Contract
7th Aug 20128:44 amRNSDirectorate Change
31st Jul 20127:00 amRNSRe Contract
25th Jul 201211:41 amRNSHolding(s) in Company
4th Jul 20127:00 amRNSPre-Close Trading Statement
18th Jun 201211:30 amRNSHolding(s) in Company
28th May 20125:04 pmRNSHolding(s) in Company
2nd May 20121:28 pmRNSDirector/PDMR Shareholding
30th Apr 201210:11 amRNSHolding(s) in Company
20th Apr 201211:05 amRNSBlocklisting Interim Review
18th Apr 20127:00 amRNSRe Contract
27th Mar 20124:54 pmRNSHalf Yearly Report
26th Mar 20124:13 pmRNSHolding(s) in Company
23rd Mar 201211:33 amRNSDirector/PDMR Shareholding
7th Mar 20123:33 pmRNSDirector/PDMR Shareholding
6th Mar 20127:00 amRNSHalf Yearly Report
6th Feb 20127:00 amRNSRe Contract
16th Jan 20127:00 amRNSTrading Update
21st Dec 201112:05 pmRNSHolding(s) in Company
8th Dec 20111:59 pmRNSHolding(s) in Company
18th Nov 20111:37 pmRNSDirector/PDMR Shareholding
17th Nov 201110:05 amRNSResult of AGM
16th Nov 20117:00 amRNSAGM Statement
7th Nov 201111:38 amRNSDirector/PDMR Shareholding
4th Nov 20112:38 pmRNSDirector/PDMR Shareholding
1st Nov 20119:31 amRNSHolding(s) in Company
31st Oct 201110:58 amRNSTotal Voting Rights
28th Oct 20117:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.